Trial Profile
A Randomized, Double-Dummy, Crossover, Single-Center Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers in the Treatment of Patients Recovering From Severe Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Mar 2019
Price :
$35
*
At a glance
- Drugs Formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 28 Feb 2019 Status changed from recruiting to completed.
- 09 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 09 Feb 2015 Planned End Date changed from 1 Dec 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.